The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immunohematology Testing Market Research Report 2024

Global Immunohematology Testing Market Research Report 2024

Publishing Date : Oct, 2023

License Type :
 

Report Code : 1803429

No of Pages : 107

Synopsis
Global Immunohematology Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immunohematology Testing market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Immunohematology Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Nihon Kohden Corporation
Diasorin S.p.A.
HemaCare Corporation
Roche Diagnostics
Siemens Healthineers
Beckman Coulter, Inc.
Abbott Laboratories
Grifols, S.A.
Ortho Clinical Diagnostics
bioMérieux
Alere, Inc.
Becton, Dickinson and Company (BD)
Thermo Fisher Scientific
Diamedix Corporation
Immucor, Inc.
Agilent Technologies, Inc.
Haemonetics Corporation
Luminex Corporation
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Segment by Type
Abo Blood Typing
Antibody Screening
Crossmatching
Direct Antiglobulin Test
Antigen Typing
Segment by Application
Transfusion Medicine
Organ and Stem Cell Transplantation
Antibody Identification and Resolution
Blood Bank Consulting
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Immunohematology Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunohematology Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Abo Blood Typing
1.2.3 Antibody Screening
1.2.4 Crossmatching
1.2.5 Direct Antiglobulin Test
1.2.6 Antigen Typing
1.3 Market by Application
1.3.1 Global Immunohematology Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Transfusion Medicine
1.3.3 Organ and Stem Cell Transplantation
1.3.4 Antibody Identification and Resolution
1.3.5 Blood Bank Consulting
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunohematology Testing Market Perspective (2018-2029)
2.2 Immunohematology Testing Growth Trends by Region
2.2.1 Global Immunohematology Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immunohematology Testing Historic Market Size by Region (2018-2023)
2.2.3 Immunohematology Testing Forecasted Market Size by Region (2024-2029)
2.3 Immunohematology Testing Market Dynamics
2.3.1 Immunohematology Testing Industry Trends
2.3.2 Immunohematology Testing Market Drivers
2.3.3 Immunohematology Testing Market Challenges
2.3.4 Immunohematology Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunohematology Testing Players by Revenue
3.1.1 Global Top Immunohematology Testing Players by Revenue (2018-2023)
3.1.2 Global Immunohematology Testing Revenue Market Share by Players (2018-2023)
3.2 Global Immunohematology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunohematology Testing Revenue
3.4 Global Immunohematology Testing Market Concentration Ratio
3.4.1 Global Immunohematology Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunohematology Testing Revenue in 2022
3.5 Immunohematology Testing Key Players Head office and Area Served
3.6 Key Players Immunohematology Testing Product Solution and Service
3.7 Date of Enter into Immunohematology Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunohematology Testing Breakdown Data by Type
4.1 Global Immunohematology Testing Historic Market Size by Type (2018-2023)
4.2 Global Immunohematology Testing Forecasted Market Size by Type (2024-2029)
5 Immunohematology Testing Breakdown Data by Application
5.1 Global Immunohematology Testing Historic Market Size by Application (2018-2023)
5.2 Global Immunohematology Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immunohematology Testing Market Size (2018-2029)
6.2 North America Immunohematology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Immunohematology Testing Market Size by Country (2018-2023)
6.4 North America Immunohematology Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunohematology Testing Market Size (2018-2029)
7.2 Europe Immunohematology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Immunohematology Testing Market Size by Country (2018-2023)
7.4 Europe Immunohematology Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunohematology Testing Market Size (2018-2029)
8.2 Asia-Pacific Immunohematology Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Immunohematology Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Immunohematology Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunohematology Testing Market Size (2018-2029)
9.2 Latin America Immunohematology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Immunohematology Testing Market Size by Country (2018-2023)
9.4 Latin America Immunohematology Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunohematology Testing Market Size (2018-2029)
10.2 Middle East & Africa Immunohematology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Immunohematology Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Immunohematology Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nihon Kohden Corporation
11.1.1 Nihon Kohden Corporation Company Detail
11.1.2 Nihon Kohden Corporation Business Overview
11.1.3 Nihon Kohden Corporation Immunohematology Testing Introduction
11.1.4 Nihon Kohden Corporation Revenue in Immunohematology Testing Business (2018-2023)
11.1.5 Nihon Kohden Corporation Recent Development
11.2 Diasorin S.p.A.
11.2.1 Diasorin S.p.A. Company Detail
11.2.2 Diasorin S.p.A. Business Overview
11.2.3 Diasorin S.p.A. Immunohematology Testing Introduction
11.2.4 Diasorin S.p.A. Revenue in Immunohematology Testing Business (2018-2023)
11.2.5 Diasorin S.p.A. Recent Development
11.3 HemaCare Corporation
11.3.1 HemaCare Corporation Company Detail
11.3.2 HemaCare Corporation Business Overview
11.3.3 HemaCare Corporation Immunohematology Testing Introduction
11.3.4 HemaCare Corporation Revenue in Immunohematology Testing Business (2018-2023)
11.3.5 HemaCare Corporation Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Immunohematology Testing Introduction
11.4.4 Roche Diagnostics Revenue in Immunohematology Testing Business (2018-2023)
11.4.5 Roche Diagnostics Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Detail
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Immunohematology Testing Introduction
11.5.4 Siemens Healthineers Revenue in Immunohematology Testing Business (2018-2023)
11.5.5 Siemens Healthineers Recent Development
11.6 Beckman Coulter, Inc.
11.6.1 Beckman Coulter, Inc. Company Detail
11.6.2 Beckman Coulter, Inc. Business Overview
11.6.3 Beckman Coulter, Inc. Immunohematology Testing Introduction
11.6.4 Beckman Coulter, Inc. Revenue in Immunohematology Testing Business (2018-2023)
11.6.5 Beckman Coulter, Inc. Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Detail
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Immunohematology Testing Introduction
11.7.4 Abbott Laboratories Revenue in Immunohematology Testing Business (2018-2023)
11.7.5 Abbott Laboratories Recent Development
11.8 Grifols, S.A.
11.8.1 Grifols, S.A. Company Detail
11.8.2 Grifols, S.A. Business Overview
11.8.3 Grifols, S.A. Immunohematology Testing Introduction
11.8.4 Grifols, S.A. Revenue in Immunohematology Testing Business (2018-2023)
11.8.5 Grifols, S.A. Recent Development
11.9 Ortho Clinical Diagnostics
11.9.1 Ortho Clinical Diagnostics Company Detail
11.9.2 Ortho Clinical Diagnostics Business Overview
11.9.3 Ortho Clinical Diagnostics Immunohematology Testing Introduction
11.9.4 Ortho Clinical Diagnostics Revenue in Immunohematology Testing Business (2018-2023)
11.9.5 Ortho Clinical Diagnostics Recent Development
11.10 bioMérieux
11.10.1 bioMérieux Company Detail
11.10.2 bioMérieux Business Overview
11.10.3 bioMérieux Immunohematology Testing Introduction
11.10.4 bioMérieux Revenue in Immunohematology Testing Business (2018-2023)
11.10.5 bioMérieux Recent Development
11.11 Alere, Inc.
11.11.1 Alere, Inc. Company Detail
11.11.2 Alere, Inc. Business Overview
11.11.3 Alere, Inc. Immunohematology Testing Introduction
11.11.4 Alere, Inc. Revenue in Immunohematology Testing Business (2018-2023)
11.11.5 Alere, Inc. Recent Development
11.12 Becton, Dickinson and Company (BD)
11.12.1 Becton, Dickinson and Company (BD) Company Detail
11.12.2 Becton, Dickinson and Company (BD) Business Overview
11.12.3 Becton, Dickinson and Company (BD) Immunohematology Testing Introduction
11.12.4 Becton, Dickinson and Company (BD) Revenue in Immunohematology Testing Business (2018-2023)
11.12.5 Becton, Dickinson and Company (BD) Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Detail
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Immunohematology Testing Introduction
11.13.4 Thermo Fisher Scientific Revenue in Immunohematology Testing Business (2018-2023)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Diamedix Corporation
11.14.1 Diamedix Corporation Company Detail
11.14.2 Diamedix Corporation Business Overview
11.14.3 Diamedix Corporation Immunohematology Testing Introduction
11.14.4 Diamedix Corporation Revenue in Immunohematology Testing Business (2018-2023)
11.14.5 Diamedix Corporation Recent Development
11.15 Immucor, Inc.
11.15.1 Immucor, Inc. Company Detail
11.15.2 Immucor, Inc. Business Overview
11.15.3 Immucor, Inc. Immunohematology Testing Introduction
11.15.4 Immucor, Inc. Revenue in Immunohematology Testing Business (2018-2023)
11.15.5 Immucor, Inc. Recent Development
11.16 Agilent Technologies, Inc.
11.16.1 Agilent Technologies, Inc. Company Detail
11.16.2 Agilent Technologies, Inc. Business Overview
11.16.3 Agilent Technologies, Inc. Immunohematology Testing Introduction
11.16.4 Agilent Technologies, Inc. Revenue in Immunohematology Testing Business (2018-2023)
11.16.5 Agilent Technologies, Inc. Recent Development
11.17 Haemonetics Corporation
11.17.1 Haemonetics Corporation Company Detail
11.17.2 Haemonetics Corporation Business Overview
11.17.3 Haemonetics Corporation Immunohematology Testing Introduction
11.17.4 Haemonetics Corporation Revenue in Immunohematology Testing Business (2018-2023)
11.17.5 Haemonetics Corporation Recent Development
11.18 Luminex Corporation
11.18.1 Luminex Corporation Company Detail
11.18.2 Luminex Corporation Business Overview
11.18.3 Luminex Corporation Immunohematology Testing Introduction
11.18.4 Luminex Corporation Revenue in Immunohematology Testing Business (2018-2023)
11.18.5 Luminex Corporation Recent Development
11.19 Bio-Rad Laboratories, Inc.
11.19.1 Bio-Rad Laboratories, Inc. Company Detail
11.19.2 Bio-Rad Laboratories, Inc. Business Overview
11.19.3 Bio-Rad Laboratories, Inc. Immunohematology Testing Introduction
11.19.4 Bio-Rad Laboratories, Inc. Revenue in Immunohematology Testing Business (2018-2023)
11.19.5 Bio-Rad Laboratories, Inc. Recent Development
11.20 Sysmex Corporation
11.20.1 Sysmex Corporation Company Detail
11.20.2 Sysmex Corporation Business Overview
11.20.3 Sysmex Corporation Immunohematology Testing Introduction
11.20.4 Sysmex Corporation Revenue in Immunohematology Testing Business (2018-2023)
11.20.5 Sysmex Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’